UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020. UNICHEM LABORATORIES LTD. - 506690 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pradeep BhandariDesignation :- Company Secretary and Compliance Officer UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.- ICRA - assigned credit rating for Rs. 146 crs (Reduced from Rs. 150 crs) bank facilities. UNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window
Pursuant to the Company''s Code of Conduct to Regulate, Conduct, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 duly amended, the Trading Window for dealing in shares of the Company will be closed from January 1, 2021 for Designated Persons, Directors, Insiders and their Immediate Relatives and shall open 48 (forty eight) hours after the financial results for the quarter and nine months ended December 31, 2020 are made public. UNICHEM LABORATORIES LTD. - 506690 - Clarification
With reference to Movement in Volume, Unichem Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed. UNICHEM LABORATORIES LTD. - 506690 - Clarification sought from Unichem Laboratories Ltd
The Exchange has sought clarification from Unichem Laboratories Ltd on December 8, 2020, with reference to Movement in Volume.The reply is awaited.
Unichem Laboratories shares rise 4% on USFDA approval for blood pressure tablets
The share touched its 52-week high Rs 304.20 and 52-week low Rs 75.10 on 04 August, 2020 and 24 March, 2020, respectively. UNICHEM LABORATORIES LTD. - 506690 - ANDA Approval From United States Food And Drug Administration (USFDA) For Unichem'S Atenolol And Chlorthalidone Tablets.
ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Atenolol and Chlorthalidone Tablets UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Advertisement Published in Business Standard (English) & Sakal (Marathi) on November 24, 2020 regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account. UNICHEM LABORATORIES LTD. - 506690 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India {Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations") For Half Year Ended September 30, 2020.
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India {Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") for half year ended September 30, 2020.